Correspondence
Letter: An observational trial: Patient profile of users of Secomet V®
South African Family Practice | Vol 52, No 2 : March/April| a1438 |
DOI: https://doi.org/10.1080/20786204.2010.10873964
| ©
Submitted: 07 September 2009 | Published: 30 April 2010
Submitted: 07 September 2009 | Published: 30 April 2010
About the author(s)
Constance E. Janse van Rensburg, University of Pretoria, South AfricaFull Text:
PDF (64KB)Abstract
No abstract available.
Keywords
Fulvic acid; HIV; CHD-FA; observational trial
Metrics
Total abstract views: 2065Total article views: 2410